LegalizeVyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů
| 180.1 | D05BB01 | etretinát | p.o. | 35 | MG | 81,14 | P |
|---|---|---|---|---|---|---|---|
| 180.2 | D05BB02 | acitretin | p.o. | 35 | MG | 81,14 | P |
| 180.3 | D05BA02 | methoxalen | p.o. | 10 | MG | 3,90 | L/DER |
| 03733 | OXSORALEN | cps 50x10mg | GER | A | |||
| 181 | D06AX | antibiotika k zevnímu použiti | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 181.1 | D06AA | tetracyklin a deriváty | lok. | 1 | GM | 2,93 | |
| 181.2 | D06AX | neomycin/ bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,91 | |
| 55762 | PAMYCON NA PRIPRAVU STER.ROZT. | plv 10x1lahv. | BTA | SK | |||
| 55759 | PAMYCON NA PRIPRAVU KAPEK | plv 1x1lahv | BTA | SK | |||
| 181.3 | D06AX | neomycin/ bacitracin (zásyp do 2 g včetně) | lok. | 1 | GM | 13,69 | |
| 181.4 | D06AX | neomycin/ bacitracin (zásyp nad 2 do 5 g v jednom balení včetně) | lok. | 1 | GM | 7,63 | |
| 181.5 | D06AX | neomycin/ bacitracin (mast) | lok. | 1 | GM | 2,93 | |
| 181.6 | D06AX | primycin | lok. | 1 | GM | 2,44 | |
| 181.7 | D06AX02 | chloramfenikol | lok. | 1 | GM | 2,88 | |
| 181.8 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1 | GM | 8,31 | |
| 181.9 | D06AX09 | mupirocin (nad 5 g v jednom balení) | lok. | 1 | GM | 5,18 | |
| 181.10 | D06AX | neomycin/ bacitracin (zásyp nad 5 g v jednom balení) | lok. | 1 | GM | 2,44 | |
| 182 | D06BA | sulfonamidy s obsahem stříbrných solí k lokálnímu podání | lok. | L/DER,CHI | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 182.1 | D06BA | sulfathiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,08 | L/DER,CHI |
| 182.2 | D06BA | sulfathiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 0,98 | L/DER,CHI |
| 182.3 | D06BA01 | sulfadiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,32 | L/DER,CHI |
| 182.4 | D06BA01 | sulfadiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 1,12 | L/DER,CHI |
| 182.5 | D06BA02 | sulfathiazol | lok. | 1 | GM | 1,03 | |
| 00899 | SULFATHIAZOL NEO-SLOVAKOFARMA | ung 1x20gm 5% | SLO | SK | |||
| 182.6 | D06BA03 | mafenid | lok. | 1 | GM | 0,98 | L/DER,CHI |
| 182.7 | D06BA51 | sulfadlazin stříbrný v kombinaci (léková forma náplasti) | lok. | 100 | CM2 | 13,49 | L/DER,CHI |
| 182.8 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma krému) | lok. | 1 | GM | 2,25 | L/DER,CHI |
| 182.9 | D06BX01 | metronidazol | lok. | 1 | GM | 2,25 | L/DER,CHI |
| 183 | D07AA | kortikosteroidy třídy I, slabě účinné | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 3,31 | |
| 00858 | HYDROCORTISON LECIVA | ung 1x10gm 1% | LEX | CZ | |||
| 183.2 | d07aa03 | prednisolon | lok. | 1 | GM | 3,18 | |
| 184 | D07AB | kortikosteroidy třídy II, středně účinné | lok. | ||||
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,18 | |
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,18 | |
| 09305 | LOCOID 0,1% | crm 1x30gm 0.1% | YEU | NL | |||
| 09307 | LOCOID 0,1% LOTION | lot 1x30ml | YEU | NL | |||
| 09310 | LOCOID 0,1% | ung 1x10gm 0.1% | YEU | NL | |||
| 26047 | LOCOID LIPOCREAM | crm 1x30gm 0.1% | YEU | NL | |||
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,18 | |
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,18 | |
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,55 | |
| 02828 | TRIAMCINOLON LECIVA | crm 1x10gm 0.1% | LEX | CZ | |||
| 02829 | TRIAMCINOLON LECIVA | ung 1x10gm 0.1% | LEX | CZ | |||
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) lok. | 1 | ML | 2,83 | ||
| 02826 | TRIAMCINOLON-GALENA | lot 1x15gm | GNO | CZ | |||
| 66167 | TRIAMCINOLON-GALENA | lot 1x30gm | GNO | CZ | |||
| 184.7 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1 | GM | 0,73 | |
| 184.8 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1 | ML | 0,98 | |
| 184.9 | D07AB10 | alclomethason | lok. | 1 | GM | 3,18 | |
| 184.10 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 3,09 | |
| 02415 | DEXAMETHAZON LECIVA | crm 10gm 0.01% | LEX | CZ | |||
| 185 | D07AC | kortikosteroidy třídy III, účinné (fluorované) | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 185.1 | D07AC01 | betamethason dipropionát | lok. | 1 | GM | 2,49 | |
| 80204 | BELODERM | ung 1x30gm 0.05% | BLU | CHO | |||
| 98034 | DIPROSONE | crm 1 x30gm | SCH | B | |||
| 88495 | KUTERID | ung 20gm | LEK | SLO | |||
| 88489 | KUTERID | crm 20gm | LEK | SLO | |||
| 98032 | DIPROSONE | ung 1x30gm | SCH | B | |||
| 80206 | BELODERM | crm 1x30gm 0.05% | BLU | CHO | |||
| 185.2 | D07AC01 | betamethason valerát | lok. | 1 | GM | 3,32 | |
| 185.3 | D07AC02 | fluklorolon | lok. | 1 | GM | 3,32 | |
| 185.4 | D07AC04 | fluocinolon gel | lok. | 1 | GM | 2,44 | |
| 185.5 | D07AC04 | fluocinolon mast a krém (koncentrace do 0,025% včetně) | lok. | 1 | GM | 2,93 | |
| 55726 | SYNALAR | crm 1x30gm | ZNC | GB | |||
| 55722 | SYNALAR | ung 1x30gm | ZNC | GB | |||
| 92285 | GELARGIN UNG | ung 1x20gm/5mg | LEX | CZ | |||
| 185.6 | D07AC04 | fluocinolon mast a krém (koncentrace nad 0,025%) | lok. | 1 | GM | 3,91 | |
| 185.7 | D07AC04 | fluocinolon lotio (koncentrace do 0,025% včetně) | lok. | 1 | GM | 2,93 | |
| 185.8 | D07AC04 | fluocinolon lotio (koncentrace nad 0,025%) | lok. | 1 | GM | 3,91 | |
| 44743 | GELARGIN FORTE LOT | lot 1x50gm/100mg | LEX | CZ | |||
| 185.9 | D07AC06 | diflukortolon | lok. | 1 | GM | 3,42 | |
| 185.10 | D07AC08 | fluocinonid | lok. | 1 | GM | 2,93 | |
| 185.11 | D07AC12 | halometason | lok. | 1 | GM | 3,27 | |
| 185.12 | D07AC17 | flutikason | lok. | 1 | GM | 3,42 | |
| 186 | D07AC | kortikosteroidy třídy III. účinné (nefluorované) | lok. | L/DER,ALG,PDD | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 186.1 | D07AC09 | budesonid | lok. | 1 | GM | 3,18 | L/DER |
| 186.2 | D07AC13 | mometazon do 10g v 1 balení včetně | lok. | 1 | GM | 6,70 | L/DER,ALG,PDD |
| 186.3 | D07AC13 | mometazon nad 10g v jednom balení | lok. | 1 | GM | 5,00 | L/DER,ALG,PDD |
| 186.4 | D07AC14 | methylprednisoni aceponas | lok. | 1 | GM | 5,87 | L/DER,ALG,PDD |
| 186.5 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1 | GM | 6,70 | L/DER,ALG,PDD |
| 83156 | DERMATOP | ung 1x10gm 2.5mg/gm | HBS | SK | |||
| 83154 | DERMATOP | crm 1x10gm 2.5mg/gm | HBS | SK | |||
| 186.6 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1 | GM | 5,87 | L/DER,ALG,PDD |
| 187 | D07AD | kortikosteroidy třídy IV, vysoce účinné | lok. | L/DER | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 187.1 | D07AD01 | klobetasol | lok. | 1 | GM | 4,40 | L/DER |
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,52 | L/DER |
| 97020 | BETACORTON | liq 1x100ml | SEG | CH | |||
| 97019 | BETACORTON | liq 1x25ml | SEG | CH | |||
| 188 | D07BB | kortikosteroidy, středně účinné, kombinace s antiseptiky | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 188.1 | D07BA01 | prednisolon/ cloroxin | lok. | 1 | GM | 1,96 | |
| 188.2 | D07BB01 | flumetason a antiseptika | lok. | 1 | GM | 3,32 | |
| 188.3 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1 | GM | 1,42 | |
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 | GM | 0,59 | |
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,60 | |
| 02827 | TRIAMCINOLON | tct 1x10ml | GNO | CZ | |||
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1.87 | |
| 04178 | TRIAMCINOLON E LECIVA | ung 1x20gm | LEX | CZ | |||
| 188.7 | D07BA01 | prednisolon/hexamidin diisothionát | lok. | 1 | GM | 1,96 | |
| 188.8 | D07CC01 | betamethason a gentamycin | lok. | 1 | GM | 2,50 | L/DER |
| 189 | D07X | kortikosteroidy, jiné kombinace | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 1,96 | |
| 189.2 | D07XA02 | prednisolon/kyselina salicylová | lok. | 1 | ML | 1,32 | |
| 189.3 | D07XB01 | flumetason/dehet | lok. | 1 | GM | 4,40 | |
| 189.4 | D07XB01 | flumethason pivalat/kyselina salicylová | lok. | 1 | GM | 2,93 | |
| 189.5 | D07XB02 | triamcinolon | lok. | 1 | GM | 1,87 | |
| 04160 | TRIAMCINOLON S LECIVA | ung 1x30gm | LEX | CZ | |||
| 189.6 | D07XC | diflucortolon/ isoconasol | lok. | 1 | GM | 2,61 | |
| 189.7 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,61 | |
| 85864 | BELOSALIC | ung 1x30gm | BLU | CHO | |||
| 189.8 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,61 | |
| 189.9 | D07XD | halcinonid/kyselina salicylová | lok. | 1 | ML | 3,57 | |
| 189.10 | D07XD | halcinonid/ močovina | lok. | 1 | GM | 3,57 | |
| 189.11 | D07CA01 | hydrocortison a antibiotika (lékové formy mastí a krémů) | lok. | 1 GM | 1,96 | ||
| 189.12 | D07CA01 | hydrocortison a antibiotika (tekuté lékové formy) | lok. | 1 | ML | 1,96 | |
| 190 | D08A | antiseptika a desinficiencia | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 190.1 | D08AC02 | chlorhexidin | lok. | 1000 | ML | 178,70 | |
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,43 | |
| 65998 | UNG.AC.BORICI 3% HERB.-BOFARMA | ung 1x1000gm (dóza) | HEO | CZ | |||
| 190.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10 | GM | 1,32 | |
| 190.4 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení) | lok. | 1 | ML | 0,98 | |
| 96605 | JODISOL SPRAY S MECH.ROZPRASOV. | spr 1x75gm | LDN | CZ | |||
| 46054 | BRAUNOL | liq 1x100ml | BMB | CH | |||
| 02981 | JODISOL ROZTOK | liq 1x80gm | LDN | CZ | |||
| 190.5 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1 | ML | 0,49 | |
| 46055 | BRAUNOL | liq 1x250ml | BMB | CH | |||
| 02983 | JODISOL ROZTOK | liq 1x760gm | LDN | CZ | |||
| 80553 | BRAUNOL | liq 1x1000ml | BMB | CH | |||
| 62319 | BETADINE (CHIRURG.) | liq 1x1000ml | EGI | H | |||
| 62317 | BETADINE | liq 1x1000ml | EGI | H | |||
| 46056 | BRAUNOL | liq 1x500ml | BMB | CH | |||
| 190.6 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1 | GM | 1,96 | |
| 84421 | BRAUNOVIDON MAST | ung 100gm (pe tuba) | BMB | CH | |||
| 190.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení) | lok. | 1 | GM | 0,98 | |
| 46052 | BRAUNOVIDON MAST | ung 250gm (pe nad.) | BMB | CH | |||
| 84422 | BRAUNOVIDON MAST | ung 250gm (pe tuba) | BMB | CH | |||
| 190.8 | D08AH kloroxin | lok. | 1 | GM | 0,78 | ||
| 190.9 | D08AJ | bromid benzododecinia (tinktura a roztok do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 190.10 | D08AJ | bromid benzododecinia (tinktura a roztok nad 50 ml v jednom balení) | lok. | 1 | ML | 0,29 | H |
| 58237 | AJATIN PROFARMA TINKTURA | tct 1x1000ml | PSR | CZ | |||
| 190.11 | D08AJ | chlorid karbetopende- cinia (tinktura 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 191 | D08AX | jiná antiseptika a desinficiencia | lok. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 191.1 | D08AX | hexamidin/ chlorhexidin | lok. | 1 | ML | 121,37 | H |
| 191.2 | D08AX | noxytiolin | lok. | 2.5 | GM | 492,11 | H |
| 191.3 | D08AX | noxytiolin/ tetrakain | lok. | 2.5 | GM | 492,11 | H |
| 191.4 | D08AX | taurolidin | lok. | 1 | GM | 94,48 | H |
| 192 | D10A | lokálně podávaná léčiva k léčbě akne | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 3,75 | |
| 58237 | AJATIN PROFARMA TINKTURA | tct 1x1000ml | PSR | CZ | |||
| 97573 | RETIN-A KREM 0.025% | crm 1x30gm | CIL | CH | |||
| 66170 | LOCACID | crm 1x30gm 0.05% | PFH | F | |||
| 192.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1 | GM | 4,40 | |
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,00 | |
| 192.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1 | ML | 4,40 | |
| 192.5 | D10AD03 | adapalen - léková forma krémů a gelů | lok. | 1 | GM | 4,00 | |
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,42 | |
| 47279 | ECLARAN 5 | gel 1x45gm | PFG | F | |||
| 192.7 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0.39 | |
| 91816 | INOXITAN | lot 100ml 50mg/ml | GNO | CZ | |||
| 192.8 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,54 | |
| 192.9 | D10AF01 | klindamycin | lok. | 1 | ML | 1,96 | |
| 192.10 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 2,93 | |
| 192.11 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1 | ML | 2,13 | |
| 98204 | ERYFLUID | sol 1x30ml | PFB | F | |||
| 192.12 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,72 | |
| 75285 | ERYFLUID | sol 1x100ml | PFB | F | |||
| 192.13 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,93 | |
| 192.14 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 1,96 | |
| 193 | D10B | celkově podávaná léčiva k léčbě akné | p.o. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 193.1 | D10BA01 | isotretinoin (do 10 MG včetně v jedné kapsli ) | p.o. | 30 | MG | 83,53 | X |
| 11685 | ROACCUTANE ROCHE | cps 30x10mg | HLR | CH | |||
| 193.2 | D10BA01 | isotretinoin (nad 10 MG v jedné kapsli) | p.o. | 30 | MG | 75,39 | X |
| 91843 | ROACCUTANE ROCHE | cps 30x20mg | HLR | CH | |||
| 194 | D11AX | jiná dermatologika | lok. | L/DER | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 194.1 | D11AX | celulóza (lékové formy zásypů) | lok. | 1 | GM | 9,78 | L/DER |
| 194.2 | D11AF | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 16,61 | L/DER |
| 60890 | VERRUMAL | liq 1x13ml | HEM | D | |||
| 194.3 | D11AF | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,15 | L/DER,ONK |
| 195 | G01AA | vaginálně podávaná antimykotika a antibiotika | vag. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu vaginálním clindamycinem ordinuje gynekolog:
- a) léčba bakteriální vaginózy v těhotenství,
- b) vaginitis s průkazem citlivosti bakteriálních kmenů na clindamycin.
| 195.1 | G01AA01 | nystatin | vag. | 100 | KU | 0,98 | |
|---|---|---|---|---|---|---|---|
| 195.2 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25 | MG | 4,11 | |
| 195.3 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25 | MG | 6,88 | |
| 78213 | PIMAFUCIN | glo vag 3x100mg | YEU | NL | |||
| 195.4 | G01AA10 | klindamycin (lékové formy krémů) | vag. | 1 | GM | 11,00 | P |
| 195.5 | G01AA51 | nystatin kombinace s neomycinem a polymyxinem | vag. | 1 | DF | 10,90 | |
| 195.6 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. čípků) | vag. | 1 | DF | 17,60 | |
| 195.7 | G01AA51 | nystatin kombinace s nifuratelem (lékové formy vag. krémů) | vag. | 5 | GM | 35,19 | |
| 196 | G01AF | vaginálně podávané imidazolové deriváty | vag. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 196.1 | G01AF20 | kombinace imidazolových derivátů - mikonazol a metronidazol ( lékové formy vag. tablet) | vag. | 1 | DF | 6,35 | |
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,46 | |
| 02430 | ENTIZOL | tbl vag 10x500mg | POL | PL | |||
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 8,25 | |
| 62862 | CANDIBENE 100MG | tbl vag 6x100mg | MCK | D | |||
| 62863 | CANDIBENE 200MG | tbl vag 3x200mg | MCK | D | |||
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 12,88 | |
| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D | |||
| 196.5 | G01AF04 | mikonazol | vag. | 0.1 | GM | 8,70 | |
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 12,88 | |
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globulí a čípků) | vag. | 0.1 | GM | 31,36 | |
| 06095 | GYNO-PEVARYL 50 | glo vag 15x50mg | CIL | CH | |||
| 196.8 | G01AF11 | ketoconazol | vag. | 0.4 | GM | 13,44 | |
| 196.9 | G01AF12 | fenticonazol | vag. | 0.1 | GM | 13,44 | |
| 196.10 | G01AF17 | oxikonazol | vag. | 0.6 | GM | 109,90 | |
| 99250 | GYNO-MYFUNGAR | tbl vag 1x600mg | LEX | CZ | |||
| 196.11 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80 | MG | 12,88 | |
| 196.12 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80 | MG | 31,28 | |
| 197 | G01AX | vaginálně podávaná jiná antiinfektiva a antiseptika | vag. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 197.1 | G01AX | laktobacillus | vag. 1 | DF | 10,26 | ||
| 197.2 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1 | DF | 17,60 | |
| 197.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5 | GM | 35,19 | |
| 197.4 | G01AX | nitrofurantoin | vag. | 0.2 | GM | 5,00 | |
| 03629 | FURANTOIN LECIVA | tbl vag 30x100mg | LEX | CZ | |||
| 197.5 | G01AX | sulfathiazol | vag. | 1 | DF | 6,60 | |
| 197.6 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1 | DF | 6,40 | |
| 197.7 | G01AX03 | polykresulen | vag. | 90 | MG | 0,35 | |
| 197.8 | G01AX05 | nifuratel | p.o. | 0.6 | GM | 15,64 | L/GYN,URN |
| 197.9 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.2 | GM | 8,94 | |
| 197.10 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.2 | GM | 6,16 | |
| 197.11 | G01AX12 | ciklopirox (vaginální krém - do 40 gm včetně v jednom balení) | vag. | 1 | GM | 4,69 | |
| 197.12 | G01AX12 | ciklopirox (vaginální krém - nad 40 gm v jednom balení) | vag. | 1 | GM | 3,11 | |
| 197.13 | G01AX12 | ciclopirox (vaginální roztok) | vag. | 1 | DF | 17,60 | |
| 197.14 | G01AX12 | ciclopirox (vaginální čípky) | vag. | 1 | DF | 31,28 | |
| 197.15 | G01AX14 | laktobacilus a estriol - vaginální tablety | vag. | 1 | DF | 16,13 | |
| 197.16 | G02CC03 | benzydamin hydrochlorid | vag. | 1 | DF | 8,00 | |
| 198 | G02AB | uterotonika ze skupiny námelových alkaloidů | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 198.1 | G02AB02 | ergotové alkaloidy | p.o. | 0.2 | MG | 1,12 | |
| 198.2 | G02AB03 | ergometrin | p.o. | 0.2 | MG | 1,12 | |
| 199 | G02AB | uterotonika ze skupiny námelových alkaloidů | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 199.1 | G02AB01 | methylergometrin | parent. | 0.2 | MG | 18,00 | |
| 00509 | METHYLERGOMETRIN SPOFA | inj 5x1 ml/0.2mg | SPX | CZ | |||
| 199.2 | G02AB03 | ergometrin | parent. | 0.2 | MG | 9,38 | |
| 200 | G02AD | uterotonika ze skupiny prostaglandinů | p.o. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 95,43 | H |
| 57150 | PROSTIN E2 | tbl 10x0.5mg | PAU | B | |||
| 201 | G02AD | uterotonika ze skupiny prostaglandinů | vag. | K/P | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje gynekolog:
- a) preindukce porodu při ukončení těhotenství,
- b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
- c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,
- d) v poporodním období při závažné metrorhagii.
| 201.1 | G02AD02 dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 770,00 | K/P | |
|---|---|---|---|---|---|---|---|
| 201.2 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1111,90 | K/P |
| 201.3 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 439,30 | K/P |
| 02289 | PROSTIN E2 | tbl vag 4x3mg | PAU | B | |||
| 201.4 | G02AD02 | dinoproston (pesar) | vag. | 1 | DF | 2200,00 | K/P |
| 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | K/P | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje gynekolog:
- a) preindukce porodu při ukončení těhotenství,
- b) indukce potratu do 24 týdne těhotenství z genetických důvodů,
- c) indukce porodu (včetně porodu mrtvého plodu) po 24 týdnu těhotenství,
- d) v poporodním období při závažné metrorhagii.
| 202.1 | G02AD01 | dinoprost | parent. | 25 | MG | 651,85 | K/P |
|---|---|---|---|---|---|---|---|
| 202.2 | G02AD02 | dinoproston | parent. | 0.5 | MG | 389,86 | K/P |
| 202.3 | G02AD04 | karboprost | parent. | 0.25 | MG | 675,61 | K/P |
| 202.4 | G02AD05 | sulproston | parent. | 0.5 | MG | 651,85 | K/P |
| 203 | G02CA | tokolytika ze skupiny beta-sympatomimetik | p.o. | P | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje gynekolog:
pouze jako pokračování parenterální aplikace tokolytik.
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 10,14 | P | | 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A | | | | | 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,14 | P | | | | | | | | | | | 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,14 | P | | 21391 | PARTUSISTEN | tbl 50x5mg | BGP | D | | | | | 204 | G02CA | tokolytika ze skupiny beta-sympatomimetik | parent. | U/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje gynekolog:
- a) zahájení tokolytické léčby po 20. týdnu těhotenství,
- b) léčba porodní dystokie,
- c) intrapartální akutní tokolýza.
| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 45,36 | U/P | | 75464 | GYNIPRAL 25RG KONCENTR.ZUR INF. | inf 5x5ml/25rg | HNP | A | | | | | 75463 | GYNIPRAL 10RG/2ML | inj 5x2ml/10rg | HNP | A | | | | | 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 45,36 | U/P | | | | | | | | | | | 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 45,36 | U/P | | 58242 | PARTUSISTEN | inf 25x10ml/0.5mg | BOE | E | | | | | 03399 | PARTUSISTEN | inf 25x10ml/0.5mg | BGP | D | | | | | 204.4 | G02CX01 | atosiban infuse | parent. | 1 | DF | 3500,00 | H | | | | | | | | | | | 204.5 | G02CX01 | atosiban injekce | parent. | 1 | DF | 1300,00 | H | | 205 | G02CB | inhibitory prolaktinu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 205.1 | G02CB | tergurid | p.o. | 1 | MG | 5,46 | | | 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ | | | | | 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 13,59 | | | 67514 | | MEDOCRIPTINE | tbl 500x2.5mg | MOE | CY | | | | 67512 | | MEDOCRIPTINE | tbl 30x2.5mg | MOE | CY | | | | 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,49 | | | | | | | | | | | | 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 27,08 | P |
Nesnášenlivost a nedostatečná účinnost jiných léků ze skupiny dopaminergních agonistů (terguridu a přípravků bromokriptinu) u nemocných s hyperprolaktinémií a prolaktin secernujícími adenomy a u nemocných s akromegalií, která je citlivá na tuto léčbu.
| 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 27,08 | Z | | 206 | G03B | androgeny | p.o. | L/END,ONK,GYN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 206.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 27,37 | L/END,ONK,GYN, SEX,URN | | | | | | | | | | | 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,04 | L/END,ONK,GYN, SEX,URN | | 09591 | PROVI RON 25 | tbl 20x25mg | SAG | D | | | | | 09592 | PROVI RON 25 | tbl 50x25mg | SAG | D | | | | | 207 | G03B | androgeny | parent. | L/END,ONK,GYN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 8,11 | L/END,ONK,GYN, SEX,URN | | 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK | | | | | 208 | G03CA | přirozené a semisyntetické estrogeny | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Estradiol, léčbu ordinuje gynekolog, sexuolog nebo endokrinolog:
- a) substituční léčba žen po předčasné menopauze,
- b) léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
Estriol, léčbu ordinuje gynekolog, urolog, sexuolog nebo endokrinolog:
léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 208.1 | G03CA | přirozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3,76 | P |
|---|---|---|---|---|---|---|---|
| 208.2 | G03CA03 | estradiol (do 1 mg v jedné tabletě včetně) | p.o. | 2 | MG | 9,00 | P |
| 208.3 | G03CA03 | estradiol (nad 1 mg do 2 mg v jedné tabletě včetně) | p.o. | 2 | MG | 6,00 | P |
| 208.4 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 2 | MG | 4,40 | P |
| 208.5 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 4,40 | P |
| 47045 | ESTRAHEXAL 25 | tts emp 6x2mg | HEX | D | |||
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 99 rg včetně/den, v rámci 28. denního cyklu) | transd. | 1 | DF | 6,00 | P |
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více rg /den, v rámci 28. denního cyklu) | transd. | 1 | DF | 9,00 | P |
| 208.8 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 5,87 | P |
| 76922 | OESTROGEL | gel 1x80gm | LBE | F | |||
| 53753 | ESTREVA | gel 1x50gm/0.05gm | THL | MC | |||
| 208.9 | G03CA03 | estradiol | vag. | 25 | RG | 9,79 | P |
| 208.10 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 208.11 | G03CA03 | estradiol (léková forma nosní spray) | inhal. | 300 | RG | 6,00 | P |
| 208.12 | G03CA04 | estriol | p.o. | 2 | MG | 6,00 | P |
| 208.13 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 98182 | OVESTIN | crm vag 1x15gm+apl. | ORG | IRL | |||
| 208.14 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 3,92 | P |
| 208.15 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,16 | P |
| 97590 | ORTHO-GYNEST D | sup vag 6 | CIL | CH | |||
| 208.16 | G03CA57 | přírodní konj. estrogeny (do 625 rg včetně v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 6,00 | P |
| 83387 | OESTROFEMINAL 0.6 | cps 21x0.6mg | MAC | D | |||
| 208.17 | G03CA57 | přírodní konj. estrogeny (nad 625 rg v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 4,34 | P |
| 09467 | OESTROFEMINAL 1.25 | cps 21x1.25mg | MAC | D | |||
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 4,35 | |
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK | |||
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK | |||
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,57 | |
| 00529 | NEOFOLLIN | inj 5x1ml/5mg | BTA | SK | |||
| 209.3 | G03CA03 | estradiol implantát | parent. | 1 | DF | 1095,00 | |
| 209.4 | G03CA04 | estriol | parent. | 2 | MG | 4,30 | |
| 210 | G03D | progestiny | p.o. | L/GYN,URN,END,INT, SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 210.1 | G03DA02 | medroxypro- gesteron | p.o. | 5 | MG | 3,62 | L/GYN,URN,END, INT,SEX |
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 15,60 | L/GYN,URN,END, INT,SEX |
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 5,20 | L/GYN,URN,END, INT,SEX |
| 210.4 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
| 01939 | NORETHISTERON SLOVAKOFARMA | tbl 30x5mg | SLO | SK | |||
| 210.5 | G03DC03 | lynestrenol | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
| 210.6 | G03DC05 | tibolon | p.o. | 2.5 | MG | 18,00 | P |
Léčbu tibolonem ordinuje gynekolog k léčbě estrogen deficitního syndromu tam, kde jsou jiné hormonální přípravky kontraindikovány nebo kde jiné hormonální přípravky pacientka objektivně nesnáší.
| 211 | G03D | progestiny | parent. | L/GYN,URN,SEX | |||
|---|---|---|---|---|---|---|---|
| 211.1 | G03DA03 | hydroxypro- gesteron | parent. | 10 | MG | 1.76 | L/GYN,URN,SEX |
| 00531 | NEOLUTIN FORTE | inj 5x1ml/125mg | SPX | CZ | |||
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 4,01 | L/GYN,URN,SEX |
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | SK | |||
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,12 | L/GYN,URN,SEX |
| 02094 | AGOLUTIN | inj 5x2ml/60mg | BTA | SK | |||
| 212 | G03E | androgeny a ženské pohlavní hormony | parent. | L/GYN,END,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 22,34 | L/GYN,END,SEX |
| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK | |||
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 73,32 | L/GYN,END,SEX |
| 213 | G03F | progestiny a estrogeny | p.o. | P | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ordinuje gynekolog, sexuolog nebo endokrinolog:
léčba postmenopausálního vegetativního a estrogen-deficitního syndromu.
| 213.1 | G03FA15 | dienogest a estradiol, fixní kombinace | p.o. | 1 | DF | 6,84 | P |
|---|---|---|---|---|---|---|---|
| 213.2 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 2 mg estradiolu v jedné tabletě | p.o. | 1 | DF | 6,84 | P |
| 213.3 | G03FA01 | norethisteron a estrogen, fixní kombinace s obsahem 1 mg estradiolu v jedné tabletě | p.o. | 1 | DF | 5,50 | P |
| 213.4 | G03FA01 | norethisteron a estrogen, fixní kombinace | transd. | 1 | DF | 6,84 | P |
| 213.5 | G03FA12 | medroxypro- gesteron a estrogen, fixní kombinace | p.o. | 1 | DF | 6,84 | P |
| 213.6 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 213.7 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | p.o. | 1 | DF | 6,84 | P |
| 213.8 | G03FB05 | norethisteron a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| 213.9 | G03FB06 | medroxypro-gesteron a estrogen, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 54310 | DIVINA | tbl 3x21(=63) | ORN | DK | |||
| 54309 | DIVINA | tbl 1x21 | ORN | DK | |||
| 213.10 | G03FB08 | dydrogesteron a estrogen, sekvenční kombinace | p.o. | 0.75 | DF | 5,08 | P |
| 213.11 | G03FB09 | levonorgestrel a estrogen, sekvenční přípravky | transd. | 1 | DF | 6,84 | P |
| 213.12 | G03FB09 | levonorgestrel a estrogen, sekvenční kombinace | p.o. | 0,75 | DF | 5,08 | P |
| 98135 | KLIMONORM | drg 1x21 | VJP | D | |||
| 89782 | KLIMONORM | drg 3x21(=63) | VJP | D | |||
| 67424 | CYCLO-MENORETTE | tbl obd 21 | WYE | D | |||
| 67425 | CYCLO-MENORETTE | tbl obd 3x21 (=63) | WYE | D | |||
| 213.13 | G03HB01 | cyproteron/ estradiol | p.o. | 0.75 | DF | 5,08 | P |
| 214 | G03GA | gonadotrofin (choriový) | parent. | L/GYN,END,PDD,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 24,59 | L/GYN,END,PDD, SEX |
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 14,98 | L/GYN,END,PDD, SEX |
| 11951 | PREGNYL | inj 3x1500ut+solv. | ORG | NL | |||
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 10,71 | L/GYN,END,PDD, SEX |
| 96314 | PREGNYL | inj 3x5000ut+solv. | ORG | NL | |||
| 215 | G03GA | gonadotrofin (lidský) | parent. | Z | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 329,64 | Z |
| 12979 | MENOGON | inj sic 10+10xsolv. | FEI | D | |||
| 43728 | MERIONAL 75 M.J. | inj sic 10x75ut+sol | IBS | CH | |||
| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH | |||
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 400,81 | Z |
| 56473 | METRODIN 75 | inj sic 1x75ut+solv | SRO | I | |||
| 56474 | METRODIN 75 | inj sic 10x75ut+sol | SRO | I | |||
| 43724 | FOSTIMON 75 M.J | inj sic 10x75ut+sol | IBS | CH | |||
| 43723 | FOSTIMON 75 M.J. | inj sic 1x75ut+solv | IBS | CH | |||
| 215.3 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75 | U | 488,79 | Z |
| 215.4 | G03GA05 | folitrofin alfa | parent. | 75 | U | 733,19 | Z |
| 215.5 | G03GA06 | folitrofin beta | parent. | 75 | U | 733,19 | Z |
| 215.6 | G03GA07 | lutropin alfa ( rekombinantní lidský luteinizační hormon) | parent. | 75 | U | 733,19 | Z |
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | L/GYN,END,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,24 | L/GYN,END,SEX,URN |
| 83672 | CLOMHEXAL | tbl 10x50mg | HEX | D | |||
| 217 | G03HA | antiandrogeny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 166,20 | |
| 77006 | ANDROCUR 10MG | tbl 15x10mg | SAG | D | |||
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 61,80 | |
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D | |||
| 59354 | ANDROCUR 100 | tbl obd 50x100mg | SUE | F | |||
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D | |||
| 218 | G03HA | antiandrogeny | parent. | L/PSY,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 125,38 | L/PSY,SEX,URN |
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D | |||
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | L/GYN,END,HEM,ALG,SEX | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 83,68 | L/GYN,END,HEM, ALG,SEX |
| 67528 | ANARGIL 200MG | cps 100x200mg | MOE | CY | |||
| 67530 | ANARGIL 200MG | cps 500x200mg | MOE | CY | |||
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY | |||
| 67527 | ANARGIL 100MG | cps 500x100mg | MOE | CY | |||
| 67525 | ANARGIL 100MG | cps 100x100mg | MOE | CY | |||
| 67526 | ANARGIL 100MG | cps 200x100mg | MOE | CY | |||
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 46,42 | L/GYN,END,HEM, ALG,SEX |
| 83580 | NEMESTRAN | cps 8x2.5mg | ROU | GB | |||
| 219.3 | G03XC01 | raloxifen | p.o. | 60 | MG | 37,40 | P |
Raloxifen: léčbu ordinuje internista, endokrinolog, revmatolog a ortoped: Postmenopauzální osteoporoza žen dokumentovaná denzitometricky (méně než -2,5 SD) nebo u žen s osteoporotickou zlomeninou, u kterých selhala hormonální substituční léčba (HRT) nebo z objektivních důvodů nelze použít HRT. Léčba je dlouhodobá, trvá nejméně dva roky. Terapie delší než dva roky pouze u pacientek s prokazatelnou zástavou úbytku kostní hmoty.
| 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | ||||
|---|---|---|---|---|---|---|---|
| 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 8,55 | |
| 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 19,55 | |
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 221.1 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,58 | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | I | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 222.1 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10 | GM | 5,97 | |
| 222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 5,97 | |
| 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX, GER | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 12,96 | L/URN,GYN,SEX GER |
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 12,96 | L/URN,GYN,SEX GER |
| 66791 | DITROPAN | tbl 30x5mg | SSF | F | |||
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 11,87 | L/URN,GYN,SEX PDD, GER |
| 92255 | MICTONETTEN | drg 30x5mg | APG | D | |||
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 5,40 | L/URN,GYN,SEX, GER |
| 66817 | MICTONORM | drg 50x15mg | APG | D | |||
| 92254 | MICTONORM | drg 30x15mg | APG | D | |||
| 66818 | MICTONORM | drg 100x15mg | APG | D | |||
| 223.5 | G04BD07 | tolterodin | p.o. | 4 | MG | 35,00 | P |
Tolterodin je indikován urologem, gynekologem, sexuologem a geriatrem při nesnášenlivosti nebo nedostatečné účinnosti jiných léků ze skupiny anticholinergik a spazmolytik (oxybutynin, propiverin) u nemocných postižených hyperaktivním měchýřem a nebo případy s těžkou hyperaktivitou měchýře. Po 3 měsících terapie tolterodinem bude přehodnocen stav pacienta na základě anamnestických údajů před zahájením terapie antimuskariniky. Pokud bude frekvence inkontinentních episod snížena o 30% a více, bude terapie tolterodinem dále hrazena z prostředků veřejného zdravotního pojištění. Pokud bude frekvence inkontinentních episod snížena o méně než 30%, nebude dále hrazena z prostředků veřejného zdravotního pojištění.
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN | |||
|---|---|---|---|---|---|---|---|
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 20,00 | L/URN |
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 20,00 | L/URN |
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 20,00 | L/URN |
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 16,80 | L/URN |
| 44311 | KORNAM 2MG | tbl 30x2mg | LEK | SLO | |||
| 44312 | KORNAM 5MG | tbl 30x5mg | LEK | SLO | |||
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 20,00 | L/URN |
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 16,00 | L/URN |
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) | p.o. | 2 | DF | 16,00 | L/URN |
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D | |||
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D | |||
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D | |||
| 224.8 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) | p.o. | 1 | DF | 16,00 | L/URN |
| 59710 | PROSTAMOL UNO | cps 30x320mg | BCE | D | |||
| 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D | |||
| 224.9 | G04CX03 | mepartricin | p.o. | 150 | KU | 20,00 | L/URN |
| 225 | H01A | hormony předního laloku hypofýzy | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 705,00 | L/J5 |
| 61227 | SAIZEN 10 | inj sic 1x10ut+5ml | SRO | CH | |||
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | O |
| 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 288,08 | H |
| 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | FRL | CZ | |||
| 226.3 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H |
| 226.4 | H01BA05 | omipresin | parent. | 5 | U | 27,57 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 22,89 | |
| 02634 | ADIURETIN | gtt nas 1x5ml/0.5mg | FRL | CZ | |||
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 22,89 | |
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 22,89 | |
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 49,20 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ | |||
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 21,96 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ | |||
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z |
| 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z |
| 45481 | SYNAREL | spr nas 1x4ml | SEA | POR | |||
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 83795 | SYNAREL | spr nas 1x8ml | SEA | POR | |||
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1600,00 | Z |
| 05981 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | IRL | |||
| 05982 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | IRL | |||
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL | |||
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL | |||
| 229.5 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0,25 MG | 1600,00 | Z | |
| 229.6 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0,25 | MG | 667,00 | Z |
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7754,00 | X |
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | |||
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5016,00 | X |
| 93867 | SANDOSTATIN | inj 1x5ml/1mg-lahv. | SAN | CH | |||
| 93866 | SANDOSTATIN | inj 5x1 ml/0.5mg | SAN | CH | |||
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 mg | parent. | 0,35 7 | MG | 1378,40 | X |
| 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 mg | parent. | 0,71 4 | MG | 1840,57 | X |
| 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 mg | parent. | 1,07 2 | MG | 2297,30 | X |
| 230.6 H01CB03 | lantreotid | parent. | 2,14 | MG | 1789,03 | X | |
| 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F | |||
| 231 | H02AA | mineralokortikoidy | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,76 | |
| 232 | H02AB | glukokortikoidy | p.o. | ||||
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | |
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 9,42 | |
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | |||
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | |
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | |
| 86606 | MEDROL 16MG | tbl 50x16mg(blistr) | PAU | B | |||
| 232.6 | H02AB07 | Prednison | p.o. | 10 | MG | 3,21 | |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | |||
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | |||
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | |||
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | |
| 80588 | CORTISON CIBA 25MG | tbl 100x25mg | CGC | CH | |||
| 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | |
| 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | |
| 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | |
| 233 | H02AB | glukokortikoidy | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 3,69 | O |
| 89869 | DIPROPHOS | inj 5x1ml | SCH | B | |||
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F | |||
| 233.3 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,21 | O |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY | |||
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | |||
| 233.4 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,50 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | ||||
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 35,70 | O |
| 233.6 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| 233.7 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
| 233.8 | H02AB06 | Prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,46 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | |||
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | |||
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 06199 | SOLU-CORTEF | inj sic 25x100mg | PAU | B | |||
| 234 | H03AA | hormony štítné žlázy | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | |
| 61160 | JODTHYROX | tbl 50 | MEC | D | |||
| 61161 | JODTHYROX | tbl 100 | MEC | D | |||
| 234.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D | |||
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D | |||
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D | |||
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D | |||
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 69191 | EUTHYROX 150 | tbl 100x150rg | MEC | D | |||
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D | |||
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 | |
| 09805 | TERTROXIN | tbl 100x0.02mg | GLA | ZA | |||
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D | |||
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 | |
| 61158 | JODID 100 | tbl 100 | MEC | D | |||
| 61159 | JODID 200 | tbl 100 | MEC | D | |||
| 235 | H03B | thyreostatika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,04 | |
| 09557 | PROPYCIL | tbl 100x50mg | SVP | D | |||
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 3,11 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | |||
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | |
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | |
| 236 | H03B | thyreostatika | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H |
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK | |||
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | L/INT,ORT,END |
| 64662 | TONOCALCIN 100I.U.NOSNI SPREJ | spr nas 1x3.5ml | MCI | CZ | |||
| 30967 | OSTEODON 100 I.U. | sprnas1x3.5ml/28dÁv | LEX | CZ | |||
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 U | 83,00 | L/INT,ORT,END | |
| 10146 | TONOCALCIN 200 I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | |||
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT, END |
| 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,ORT, END |
| 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | |||
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | |||
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | |||
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | |||
| 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D | |||
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | |
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,01 | |
| 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,01 | |
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | |
| 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 6,26 | |
| 241 | J01AA | tetracyklinová antibiotika | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 91,28 | K |
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | |||
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | |||
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25,88 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | |||
| 243 | J01BA | amfenikolová antibiotika | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 267,93 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | |||
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 14,13 | |
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | |
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1 tabletě včetně | p.o. | 1 | GM | 10,12 | |
| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D | |||
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | |||
| 66364 | OSPAMOX 250MG | cps 12x250mg | BCA | A | |||
| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D | |||
| 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A | |||
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | |||
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | |||
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | |||
| 32557 | OSPAMOX 500 MG | por tbl obd14x500mg | BCA | A | |||
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1tabletě | p.o. | 1 | GM | 9,06 | |
| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D | |||
| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D | |||
| 32558 | OSPAMOX 750 MG | por tbl obd14x750mg | BCA | A | |||
| 32559 | OSPAMOX 1000 MG | por tblobd 14x1000mg | BCA | A | |||
| 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A | |||
| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D | |||
| 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D | |||
| 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D | |||
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | |||
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | |||
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | |||
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | |||
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A | |||
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A | |||
| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D | |||
| 44347 | AMOXIHEXAL FORTF | plv sus 1x100ml | AAG | D | |||
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | |||
| 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1 | GM | 10,00 | |
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D | |||
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D | |||
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | |||
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | |||
| 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K | |||
| 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K |
| 246 | J01CA | acylureidová antibiotika | parent. | U/ATB | |||
| 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB |
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB |
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 247.1 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | |||
| 92434 | V-PENICILIN 0.4MEGA BIOTIKA | tbl 30x400ku | BTA | SK | |||
| 247.2 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 45996 | OSPEN 500 | tbl obd 30x500ku | BCA | A | |||
| 56831 | OSPEN 500 | tbl obd 12x500ku | BCA | A | |||
| 92435 | V-PENICILIN 0.8MEGA BIOTIKA | tbl 30x800ku | BTA | SK | |||
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | |||
| 247.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-blistr | SLO | SK | |||
| 92436 | V-PENICILIN 1.2MEGA BIOTIKA | tbl 30x1.2mu | BTA | SK | |||
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | |||
| 30069 | PENCID 1000 | tbl obd 30x1mu | LEX | CZ | |||
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | |||
| 49513 | PENBENE | tbl obd 30x1mu | MCK | D | |||
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | |||
| 65356 | PENBENE | tbl obd 12x1mu | MCK | D | |||
| 57778 | PENBENE 1500000 | tbl obd 21 | MCK | D | |||
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | |||
| 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | |||
| 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A | |||
| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-blistr | SLO | SK | |||
| 45997 | OSPEN 1000 | tbl obd 30x1000ku | BCA | A | |||
| 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 15,05 | |
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | |||
| 247.5 | J01CE10 | benzathin fenoxymethyl-penicilin | p.o. | 2 | GM | 29,43 | |
| 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO | |||
| 49549 | OSPEN 400MG | sir 1x150ml | BCA | A | |||
| 247.6 | J01CE02 | fenoxymethyl-penicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
| 247.7 | J01CE02 | fenoxymethyl-penicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | |||
| 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK | |||
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | |||
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 27,83 | K |
| 01764 | RATARPEN 2.4 M.U.I. | inj sic 50x2,4mu | BCA | A | |||
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK | |||
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K |
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK | |||
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I | |||
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 95,80 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | |||
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 251.1 | J01CR04 sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | ||
| 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
| 46093 | ENHANCIN 250/125MG | tbl obd 21x250mg | RXY | IND | |||
| 97657 | AUGMENTIN 375MG | tbl obd 21x375mg | LEX | CZ | |||
| 85524 | AMOKSIKLAV | tbl obd 21x375mg | LEK | SLO | |||
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
| 83738 | AUGMENTIN 625MG | tbl obd 21x625mg | LEX | CZ | |||
| 46094 | ENHANCIN 500/125MG | tbl obd 21x500mg | RXY | IND | |||
| 85525 | AMOKSIKLAV | tbl obd 21x625mg | LEK | SLO | |||
| 53577 | CURAM 625MG | tbl obd 21x625mg | BCA | A | |||
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 53959 | AUGMENTIN 1GM | tbl obd 14x1gm | LEX | CZ | |||
| 12494 | AUGMENTIN 1GM | tbl 14x1gm | SKB | GB | |||
| 05951 | AMOKSIKLAV 1G | tbl obd 14x1gm | LEA | SLO | |||
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | |
| 97658 | AUGMENTIN 156MG/5ML | sir sic 1x100ml | LEX | CZ | |||
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | |||
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | |
| 83739 | AUGMENTIN 312MG/5ML | sir sic 1x100ml | LEX | CZ | |||
| 53571 | CURAM 312.5MG/5ML | plv sus 1x100ml | BCA | A | |||
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB |
| 32279 | AMOKSIKLAV 600 MG | inj sic 5x600mg | LEA | SLO | |||
| 97660 | AUGMENTIN 1.2GM | inj sic 5x1.2gm | LEX | CZ | |||
| 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO | |||
| 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO | |||
| 32280 | AMOKSIKLAV 1.2 G | inj sic 5x1.2gm | LEA | SLO | |||
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | |||
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | |||
| 06158 | ORACEF | cps 16x500mg | KRK | SLO | |||
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | |||
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | |||
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | |||
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | |||
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 71,43 | |
| 53153 | VERCEF 250MG | cps 7x3(blistr) | RXY | IND | |||
| 58765 | SERVICLOR 250 MG | cps 21x250mg | BCA | A | |||
| 47210 | VERCEF MR 375 MG | por tblret 14x375mg | RXY | IND | |||
| 01665 | CEFACLOR 250-SL | cps 21x250mg | SLO | SK | |||
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | |
| 32156 | SERVICLOR 500 MG | cps 21x500mg | BCA | A | |||
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | |||
| 01667 | CEFACLOR 500-SL | cps 21x500mg | SLO | SK | |||
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D | |||
| 53157 | VERCEF 500MG | cps 7x3(blistr) | RXY | IND | |||
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | |
| 58763 | SERVICLOR 125 MG/5ML | por gra sus 1x100ml | BCA | A | |||
| 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | |
| 53152 | VERCEF 250MG/5ML | plv sus 1x100ml | RXY | IND | |||
| 58764 | SERVICLOR 250 MG/5ML | por gra sus 1x100ml | BCA | A | |||
| 66282 | CEFACLOR AL SUSP. | gra sus 1x100ml/5gm | APA | D | |||
| 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 40,00 | |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A | |||
| 44799 | BIODROXIL | cps 12x500mg | BCA | A | |||
| 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 63,30 | |
| 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| 253.12 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB |
| 253.13 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.14 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog:
- a) inciální léčba bakteriální meningitidy u dětí mladších 18 let,
- b) léčba Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
- c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)